Jul 5, 2022 Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
May 16, 2022 Syros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides a Corporate Update
Apr 8, 2022 Syros Presents New Preclinical Data on its CDK12 Inhibitor Program at American Association for Cancer Research (AACR) Annual Meeting 2022
